CODEINE MARKET ANALYSIS
Codeine Market Regional Analysis
North America codeine market is expected to hold a dominant position in the global codeine market and to account for largest market share over the forecast period, owing to high presence of key players in the region and approval and launch of novel products by them in the region.
For instance, in 2015, Tris Pharma, Inc. received U.S. Food and Drug Administration approval and launched its Tuzistra XR (codeine polistirex and chlorpheniramine polistirex), extended-release oral suspension, CIII (DEA Schedule III) in the U.S. market. Tuzistra XR is indicated for the treatment and relief of cough and symptoms associated with upper respiratory allergies or a common cold in adults aged 18 years and older.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
